Clinical Trials

Health Olivia Goldhill

‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability

A STAT Investigation Jason Mast

Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups

Health Angus Chen

‘It still prevented cancers’: Experts discuss furor over colonoscopy screening study and dissect the nuances

Health Tech Katie Palmer

At Verily, a growing line of business builds on a revolving door to the FDA

Pharmalot Ed Silverman

What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency

Pharmalot Ed Silverman

‘A blind eye’: NIH fails to ensure clinical trial results are reported, and still funds researchers who don’t file results

D.C. Diagnosis Elissa Welle

Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep

Health Elissa Welle

Monoclonal antibody treatment for malaria shows encouraging results

Pharmalot Ed Silverman

Major European research funders often fail to set policies or monitor progress on clinical trial transparency

Health Tech Mario Aguilar

Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk

Health Tech Mario Aguilar and Mohana Ravindranath

Remote technology could nudge patients to join cancer clinical trials

Special Report Angus Chen

This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women

Pharmalot Ed Silverman

The World Health Assembly moves to bolster clinical trials, but some say it falls short

Biotech Kate Sheridan

When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

Pharmalot Ed Silverman

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

Pharmalot Ed Silverman

In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials

First Opinion Podcast Patrick Skerrett

Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?

Matt's Take Matthew Herper

New Covid trial results may point toward better ways to study medicines

Pharmalot Ed Silverman

‘Harmful and wasteful’: Many pediatric clinical trials end early and don’t report results

Health Tech Matthew Herper

Virtual Event: Taking the pulse of clinical trials

Pharmalot Ed Silverman

Political pressure in the U.K. prompted more universities to report clinical trial results

Pharmalot Ed Silverman

No more waffling: Belgium discloses penalties for failing to report clinical trial results

Pharmalot Ed Silverman

Insufficient progress is being made in reporting clinical trial results in the U.S.

Pharmalot Ed Silverman

Trial by fire: More study protocols are experiencing substantial — and costly — changes

Matt's Take Matthew Herper

clinical trials

Most Read

Health app companies wrestle with how to design studies to prove treatments work

On the Texas-Mexico border, a bold plan to diversify Alzheimer’s research takes shape

Some European regulators are starting to take steps to ensure clinical trial results are reported

New details on Apple Watch study emphasize Medicaid enrollment

House Democrat presses bill to encourage more diversity in clinical trials run by NIH

Cancer treatment devised in the 1980s has proven effective (again). Will it finally get approval?

Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach

The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients

All Coverage

‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability

Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups

‘It still prevented cancers’: Experts discuss furor over colonoscopy screening study and dissect the nuances

At Verily, a growing line of business builds on a revolving door to the FDA

What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency

‘A blind eye’: NIH fails to ensure clinical trial results are reported, and still funds researchers who don’t file results

Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep

Monoclonal antibody treatment for malaria shows encouraging results

Major European research funders often fail to set policies or monitor progress on clinical trial transparency

Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk

Remote technology could nudge patients to join cancer clinical trials

This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women

The World Health Assembly moves to bolster clinical trials, but some say it falls short

When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials

Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?

New Covid trial results may point toward better ways to study medicines

‘Harmful and wasteful’: Many pediatric clinical trials end early and don’t report results

Virtual Event: Taking the pulse of clinical trials

Political pressure in the U.K. prompted more universities to report clinical trial results

No more waffling: Belgium discloses penalties for failing to report clinical trial results

Insufficient progress is being made in reporting clinical trial results in the U.S.

Trial by fire: More study protocols are experiencing substantial — and costly — changes

Robert Califf is a fervent believer in data. At the FDA, will that be enough?

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day